{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:07:58Z","timestamp":1763755678946,"version":"3.45.0"},"reference-count":52,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2012,10,1]]},"DOI":"10.1188\/12.cjon.507-513","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T20:39:20Z","timestamp":1349037560000},"page":"507-513","source":"Crossref","is-referenced-by-count":5,"title":["Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation Recipients"],"prefix":"10.1188","volume":"16","author":[{"given":"Elisabeth C.","family":"Sosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2012,9,28]]},"reference":[{"key":"1","first-page":"513","volume-title":"Cancer nursing: Principles and practice","author":"L. Anderson-Reitz","year":"2011"},{"key":"2","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","article-title":"Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation","volume":"109","author":"P. Armand","year":"2007","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial","volume":"79","author":"M. Attal","year":"1992","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"S. Bearman","year":"1995","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Veno-occlusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation","volume":"11","author":"S. Bearman","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"6","first-page":"407","article-title":"A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation","volume":"5","author":"S. Bearman","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"7","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V80.8.2149.2149","article-title":"Prevention of veno-occlusive disease of the liver after bone marrow transplantation: Heparin or no heparin?","volume":"80","author":"J. Cahn","year":"1992","journal-title":"Blood"},{"key":"8","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation and Marrow Transplantation Chronic Leukemia Working Party","volume":"92","author":"E. Carreras","year":"1998","journal-title":"Blood"},{"key":"9","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"E. Carreras","year":"2011","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Y. Chalandon","year":"2004","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: Results of the European compassionate use study","volume":"111","author":"R. Chopra","year":"2000","journal-title":"British Journal of Haematology"},{"key":"12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0268-960X(03)00002-X","article-title":"Veno-occlusive disease: Cytokines, genetics, and haemostasis","volume":"17","author":"J. Coppell","year":"2003","journal-title":"Blood Reviews"},{"key":"13","first-page":"157","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome","volume":"16","author":"J. Coppell","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"14","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1182\/blood-2008-07-169342","article-title":"Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation","volume":"112","author":"C. Cutler","year":"2008","journal-title":"Blood"},{"key":"15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: Minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"F. Dignan","year":"2007","journal-title":"Bone Marrow Transplantation"},{"key":"16","first-page":"225","article-title":"Association of busulfan area under the curve with veno-occlusive disease following BMT","volume":"17","author":"S. Dix","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1188\/08.ONF.385-397","article-title":"Hepatic sinusoidal obstruction syndrome in patients undergoing hematopoietic stem cell transplant","volume":"35","author":"S. Eisenberg","year":"2008","journal-title":"Oncology Nursing Forum"},{"issue":"12","key":"18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation: A randomized, double-blind, placebo-controlled trial","volume":"128","author":"J. Essell","year":"1998","journal-title":"Annals of Internal Medicine"},{"key":"19","first-page":"367","article-title":"Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients","volume":"10","author":"J. Essell","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"20","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V79.10.2784.2784","article-title":"Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan\/cyclophosphamide","volume":"79","author":"J. Essell","year":"1992","journal-title":"Blood"},{"key":"21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/sj.bmt.1704087","article-title":"Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: A prospective phase II study","volume":"31","author":"D. Forrest","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"22","first-page":"813","article-title":"Hepatic veno-occlusive disease following bone marrow transplantation","volume":"16","author":"N. Grandt","year":"1989","journal-title":"Oncology Nursing Forum"},{"key":"23","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1182\/blood.V92.12.4568","article-title":"Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation","volume":"92","author":"H. Hagglund","year":"1998","journal-title":"Blood"},{"key":"24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Veno-occlusive disease of the liver following bone marrow transplantation","volume":"44","author":"R. Jones","year":"1987","journal-title":"Transplantation"},{"key":"25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4065\/78.5.589","article-title":"Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation","volume":"78","author":"S. Kumar","year":"2003","journal-title":"Mayo Clinic Proceedings"},{"key":"26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00277-004-0982-4","article-title":"Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan versus oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation","volume":"84","author":"J. Lee","year":"2005","journal-title":"Annals of Hematology"},{"key":"27","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1182\/blood-2009-03-212282","article-title":"Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation","volume":"114","author":"S. Maradei","year":"2009","journal-title":"Blood"},{"key":"28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation","volume":"47","author":"L. Marsa-Vila","year":"1991","journal-title":"European Journal of Haematology"},{"key":"29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients","volume":"118","author":"G. McDonald","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Veno-occlusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors","volume":"4","author":"G. McDonald","year":"1984","journal-title":"Hepatology"},{"key":"31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/10245332.1999.11746478","article-title":"BMT: Serum ferritin as risk factor for veno-occlusive disease of the liver: Prospective cohort study","volume":"4","author":"M. Morado","year":"2000","journal-title":"Hematology"},{"key":"32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"K. Ohashi","year":"2000","journal-title":"American Journal of Hematology"},{"key":"33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbmt.2009.01.013","article-title":"The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms","volume":"15","author":"M. Palomo","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.bbmt.2010.02.008","article-title":"Endothelial dysfunction after hematopoietic stem cell transplantation: Role of the conditioning regimen and the type of transplantation","volume":"16","author":"M. Palomo","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol versus heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"S. Park","year":"2002","journal-title":"Bone Marrow Transplantation"},{"key":"36","unstructured":"Pasquini, M. C., & Wang, Z. (2011). Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2011. Retrieved from <a target=\"_blank\" href='http:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/Pages\/index.aspx#CiteSummarySlides'>http:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/Pages\/index.aspx#CiteSummarySlides<\/a>"},{"key":"37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","article-title":"Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: Results of the EVTAC trial","volume":"15","author":"U. Platzbecker","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.bmt.1705528","article-title":"Incidence and management of hepatic veno-occlusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)","volume":"38","author":"K. Ramasamy","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"39","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"P. Richardson","year":"1998","journal-title":"Blood"},{"key":"40","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"P. Richardson","year":"2002","journal-title":"Blood"},{"key":"41","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: A multicenter, randomized, dose-finding trial","volume":"16","author":"P. Richardson","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"42","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V67.6.1773.1773","article-title":"Thrombocytopenia in veno-occlusive disease after bone marrow transplantation or chemotherapy","volume":"67","author":"B. Rio","year":"1986","journal-title":"Blood"},{"key":"43","first-page":"541","volume-title":"Critical care nursing","author":"L. Robinson","year":"2005"},{"key":"44","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"T. Ruutu","year":"2002","journal-title":"Blood"},{"issue":"1-2","key":"45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10428199909093722","article-title":"The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation","volume":"33","author":"C. Salat","year":"1999","journal-title":"Leukemia and Lymphoma"},{"key":"46","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"C. Salat","year":"1997","journal-title":"Blood"},{"key":"47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1188\/07.CJON.53-63","article-title":"Hematopoietic stem cell transplantation: Implications for critical care nurses","volume":"11","author":"M. Saria","year":"2007","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"48","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms","volume":"19","author":"H. Shulman","year":"1994","journal-title":"Hepatology"},{"key":"49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: Possible beneficial use of low molecular weight heparin","volume":"27","author":"M. Simon","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"50","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.transproceed.2009.11.049","article-title":"Iron overload: Predictor of adverse outcomes in hematopoietic stem cell transplantation","volume":"42","author":"G. Sucak","year":"2010","journal-title":"Transplantation Proceedings"},{"key":"51","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.bmt.1702624","article-title":"Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: A prospective single center study","volume":"26","author":"S. Tanikawa","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0749-2081(05)80043-9","article-title":"Selected complications of allogeneic bone marrow transplantation","volume":"10","author":"D. Wujcik","year":"1994","journal-title":"Seminars in Oncology Nursing"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/11324JG274127751.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:54:59Z","timestamp":1763754899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/16\/5\/veno-occlusive-disease-hematopoietic-stem-cell-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,28]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10,1]]}},"alternative-id":["11324JG274127751"],"URL":"https:\/\/doi.org\/10.1188\/12.cjon.507-513","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2012,9,28]]}}}